Recipharm Venture Fund (investor - Venture Capital)

See something wrong or missing? Let us know
Offices:
Stockholm
Average round investment:
14.72M USD

Recipharm Venture Fund is part of Recipharm AB, a publicly listed Swedish company, active as a pharmaceutical contract development and manufacturing organization.

We tracked 2 Nordic investments.

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Recipharm Venture Fund investments breakdown analysis:

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Investors with similar profile to Recipharm Venture Fund:

InvestorCriteria
New Enterprise Associates
36%
  • Range for average deal size: 10M - 20M USD
  • Average number of deals per year: 1.4
  • Active last 12 months: Yes
Spain Kibo Ventures
36%
  • Range for average deal size: 10M - 20M USD
  • Average number of deals per year: 1.1
  • Active last 12 months: Yes
Earlybird Venture Capital
36%
  • Range for average deal size: 10M - 20M USD
  • Average number of deals per year: 1
  • Active last 12 months: Yes
Sweden Zobito
34%
  • Range for average deal size: 10M - 20M USD
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
Dawn Capital
34%
  • Range for average deal size: 10M - 20M USD
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
Sweden Sebastian Siemiatkowski
34%
  • Range for average deal size: 10M - 20M USD
  • Average number of deals per year: 2
  • Active last 12 months: Yes
Denmark Novo A/S
34%
  • Range for average deal size: 10M - 20M USD
  • Average number of deals per year: 1.6
  • Active last 12 months: Yes
Local Globe
34%
  • Range for average deal size: 10M - 20M USD
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
PROfounders Capital
33%
  • Range for average deal size: 10M - 20M USD
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
Partech Ventures
33%
  • Range for average deal size: 10M - 20M USD
  • Average number of deals per year: 1.4
  • Active last 12 months: Yes

News about Recipharm Venture Fund

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)